Edwards Lifesciences Stock Forecast

Stock Price Forecast

The 19 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $96.37, which forecasts a 17.52% increase in the stock price over the next year. The lowest target is $81 and the highest is $110.

Price Target: $96.37 (+17.52%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$81	$96.37	$97	$110
Change	-1.22%	+17.52%	+18.29%	+34.15%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	7	6	7	7	7	7
Buy	6	7	7	7	7	7
Hold	7	7	7	7	7	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	21	21	21	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Miksic Barclays	Barclays	Buy Maintains $104 → $110	Buy	Maintains	$104 → $110	+34.15%	Apr 27, 2026
Vijay Kumar Evercore ISI Group	Evercore ISI Group	Buy Maintains $92 → $93	Buy	Maintains	$92 → $93	+13.41%	Apr 24, 2026
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $89 → $90	Hold	Maintains	$89 → $90	+9.76%	Apr 24, 2026
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $87 → $85	Hold	Maintains	$87 → $85	+3.66%	Apr 24, 2026
Marie Thibault BTIG	BTIG	Strong Buy Maintains $98 → $100	Strong Buy	Maintains	$98 → $100	+21.95%	Apr 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.88B

from 6.07B

13.39%

from 6.07B

Revenue Next Year

7.56B

from 6.88B

9.81%

from 6.88B

EPS This Year

3.01

from 1.83

64.38%

from 1.83

EPS Next Year

3.37

from 3.01

11.96%

from 3.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.23B	4.46B	5.01B	5.44B	6.07B	6.88B	7.56B
Revenue Growth	19.29%	-14.69%	12.23%	8.57%	11.55%	13.39%	9.81%
EPS	2.38	2.44	2.30	6.97	1.83	3.01	3.37
EPS Growth	83.08%	2.40%	-5.44%	202.39%	-73.70%	64.38%	11.96%
Forward PE	-	-	-	-	-	27.22	24.31
No. Analysts	-	-	-	-	-	37	36

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	7.1B	7.9B
Avg	6.9B	7.6B
Low	6.5B	7.0B

Revenue Growth

Revenue Growth	2026	2027
High	17.2%	15.2%
Avg	13.4%	9.8%
Low	6.8%	2.0%

EPS Forecast

EPS	2026	2027
High	3.18	3.60
Avg	3.01	3.37
Low	2.30	2.59

EPS Growth

EPS Growth	2026	2027
High	73.2%	19.5%
Avg	64.4%	12.0%
Low	25.6%	-14.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.